Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.
Shelley Johns, PsyD

A paper by a Regenstrief Institute and Indiana University School of Medicine research scientist in the highly influential journal, “Cancer,” was among the journal’s top 10 percent most-downloaded papers of the last year.

The study was a randomized controlled trial that found that acceptance and commitment therapy (ACT) helped cancer survivors cope with their fear that cancer would return.

Shelley Johns, PsyD, was the first author on the paper. She is a research scientist with Regenstrief’s Center for Health Services Research, an assistant professor and an adjunct associate professor of psychiatry at the IU School of Medicine, and a research scientist and a clinical health psychologist at Eskenazi Health.

The study is the first of its kind. Results showed that breast cancer survivors who received ACT showed significantly larger improvements in dealing with the fear of recurrence when compared to survivors who received other treatments. Fear of recurrence is very common in survivors of cancer, causing anxiety, depression and diminished quality of life. Up to 70 percent of breast cancer survivors report that the fear affects their daily life.

In ACT, therapists work with survivors to practice mindfulness, helping them pay attention to the present moment without letting fears about the future interfere with their quality of life.

The study compared the effect of ACT, survivorship education and enhanced usual care on fear of recurrence. The research team assessed the participants’ fear at the beginning of the study, immediately after the intervention, one month after, and then six months after. Each of the three groups showed reductions in the severity of their fear, but only ACT led to significant improvements at each evaluation, and the effect continued to grow as time went on.

In addition, the success of recruitment and retention rates in the study demonstrated that this treatment is feasible.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Nov 24, 2020 • News
Regenstrief, IU fellows author peer-reviewed papers
Supporting and encouraging the next generation of research scientists is crucial to the mission of the Regenstrief Institute. The institute and Indiana University Richard M. Fairbanks School of Public Health at IUPUI manage a National Library of Medicine T15 training program in public and population health informatics. Several pre-doctoral fellows have published articles in peer-reviewed journals based on their research through this program.   Opeyemi Ojo, MPH, a doctoral…
Continue Reading >
Nov 20, 2020 • News
Nursing home residents with POLST forms three times more likely to have preferences known
Nursing home residents with medical order forms indicating their treatment preferences were three times more likely to have their current preferences documented in their medical record than residents without the forms, according to a study from Indiana University School of Nursing and IU Center for Aging Research at Regenstrief Institute.   POLST is a medical order…
Continue Reading >